Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

doi:10.1136/annrheumdis-2013-204016corr1

Article Text

See original article:

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study - February 01, 2015

Electronic pages

Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

https://doi.org/10.1136/annrheumdis-2013-204016corr1

Statistics from Altmetric.com

Tanaka Y, Hirata S, Kubo S, et al. Discontinuation of adalimumab after …

View Full Text

Linked Articles

Clinical and epidemiological research
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka Shintaro Hirata Satoshi Kubo Shunsuke Fukuyo Kentaro Hanami Norifumi Sawamukai Kazuhisa Nakano Shingo Nakayamada Kunihiro Yamaoka Fusae Sawamura Kazuyoshi Saito
Annals of the Rheumatic Diseases 2013; 74 389-395 Published Online First: 28 Nov 2013. doi: 10.1136/annrheumdis-2013-204016

Log in using your username and password

Main menu

Log in using your username and password

You are here

See original article:

Statistics from Altmetric.com

Linked Articles

Read the full text or download the PDF:

Log in using your username and password

Read the full text or download the PDF:

Log in using your username and password